Evidence map›Paper›PMID 30885233›Full record

Trial reportLipids in health and disease2019

Lower HDL-cholesterol, a known marker of cardiovascular risk, was associated with depression in type 1 diabetes: a cross sectional study.

Eva Olga Melin, Hans Olav Thulesius, Magnus Hillman, Ralph Svensson, Mona Landin-Olsson, Maria Thunander

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Lipids in health and disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Multidisciplinary Therapy to Target Obesity and Its Complications in Adult Population: A Narrative Review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. The Interconnected Complexity of Diabetes and Depression.Diabetes spectrum : a publication of the American Diabetes Association · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Eva Olga MelinDepartment of Clinical Sciences, Diabetes Research Laboratory, Lund University, Lund, Sweden. eva.melin@kronoberg.se.ORCID http://orcid.org/0000-0002-7835-2650
Hans Olav ThulesiusResearch and Development, Region Kronoberg, Växjö, Sweden.
Magnus HillmanDepartment of Clinical Sciences, Diabetes Research Laboratory, Lund University, Lund, Sweden.
Ralph SvenssonDepartment of Psychology, Linnaeus University, Växjö, Sweden.
Mona Landin-OlssonDepartment of Clinical Sciences, Diabetes Research Laboratory, Lund University, Lund, Sweden.
Maria ThunanderDepartment of Clinical Sciences, Diabetes Research Laboratory, Lund University, Lund, Sweden.
Lund University · SELinnaeus University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDepression, metabolic disturbances and inflammation have been linked to cardiovascular disease and mortality. Low levels of high-density lipoprotein cholesterol (HDL-cholesterol), a known marker of cardiovascular risk, have been observed in patients with major depression in psychiatric populations. Our main aim was to explore associations between depression, antidepressants, and metabolic and inflammatory variables in patients with type 1 diabetes (T1D). A secondary aim was to explore variables associated with HDL-cholesterol.

methodsCross-sectional design. T1D patients (n = 292, men 55%, age18-59 years, diabetes duration ≥1 year) were consecutively recruited from one specialist diabetes clinic. Depression was defined as ≥8 points for Hospital Anxiety and Depression Scale-Depression sub scale. Blood samples, anthropometrics, blood pressure, and data regarding medication and life style were collected from electronic health records. Non-parametric tests, multiple logistic and linear regression analyses were performed.

resultsThe depression prevalence was 10 and 8% used antidepressants. Median (q

conclusionsLower HDL-cholesterol levels, known predictors of cardiovascular disease, were associated with depression in patients with T1D. The use of antidepressants was associated with abdominal obesity in women. Depression, low-grade inflammation measured as hs-CRP, higher triglycerides, male sex, and lower age were independently associated with lower HDL-cholesterol levels.

Indexed as

AdolescentAdultAntidepressive AgentsBiomarkersCholesterol, HDLCross-Sectional StudiesDepressionDiabetes Mellitus, Type 1FemaleGlycated HemoglobinHumansMaleMiddle AgedObesity, AbdominalAntidepressive AgentsBiomarkersCholesterol, HDLGlycated Hemoglobinhemoglobin A1c protein, humanAntidepressantsDepressionLow-grade inflammationSerum-lipidsType 1 diabetes

Identifiers

PMID30885233
PMCPMC6421645
OpenAlexW2941105258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.